Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Ferguson

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Oncotarget|May 3, 2014
Indoleamine 2,3-dioxygenase mediates immune-independent human tumor cell resistance to olaparib, gamma radiation, and cisplatinSaman Maleki Vareki, Mateusz Rytelewski, Rene Figueredo, et al.
Plos One|November 19, 2015
IDO Downregulation Induces Sensitivity to Pemetrexed, Gemcitabine, FK866, and Methoxyamine in Human Cancer CellsSaman Maleki Vareki, Di Chen, Christine Di Cresce, et al.
European Journal of Immunology|January 17, 2020
CD5 blockade enhances ex vivo CD8<sup>+</sup> T cell activation and tumour cell cytotoxicityFaizah Alotaibi, Mateusz Rytelewski, Rene Figueredo, et al.
Oncotarget|March 10, 2016
Reciprocal positive selection for weakness - preventing olaparib resistance by inhibiting BRCA2Mateusz Rytelewski, Saman Maleki Vareki, Lingegowda S Mangala, et al.
Molecular Oncology|June 30, 2014
BRCA2 inhibition enhances cisplatin-mediated alterations in tumor cell proliferation, metabolism, and metastasisMateusz Rytelewski, Jessica G Tong, Adrian Buensuceso, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Oncotarget|May 3, 2014
Indoleamine 2,3-dioxygenase mediates immune-independent human tumor cell resistance to olaparib, gamma radiation, and cisplatinSaman Maleki Vareki, Mateusz Rytelewski, Rene Figueredo, et al.
Plos One|November 19, 2015
IDO Downregulation Induces Sensitivity to Pemetrexed, Gemcitabine, FK866, and Methoxyamine in Human Cancer CellsSaman Maleki Vareki, Di Chen, Christine Di Cresce, et al.
European Journal of Immunology|January 17, 2020
CD5 blockade enhances ex vivo CD8<sup>+</sup> T cell activation and tumour cell cytotoxicityFaizah Alotaibi, Mateusz Rytelewski, Rene Figueredo, et al.
Oncotarget|March 10, 2016
Reciprocal positive selection for weakness - preventing olaparib resistance by inhibiting BRCA2Mateusz Rytelewski, Saman Maleki Vareki, Lingegowda S Mangala, et al.
Molecular Oncology|June 30, 2014
BRCA2 inhibition enhances cisplatin-mediated alterations in tumor cell proliferation, metabolism, and metastasisMateusz Rytelewski, Jessica G Tong, Adrian Buensuceso, et al.
Pageof 2